Authors:Matthew D Hall, National Institutes of Health, RockvilleJames M Anderson, National Institutes of Health, BethesdaAnnaliesa Anderson, Pfizer Vaccine Research and DevelopmentDavid Baker, University of WashingtonJay Bradner, Novartis Institutes for BioMedical ResearchKyle R Brimacombe, National Institutes of Health, RockvilleElizabeth A Campbell, Rockefeller UniversityKizzmekia S Corbett, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaKara Carter, EvotecSara Cherry, University of PennsylvaniaLillian Chiang, Evrys Bio, DoylestownTomas Cihlar, Gilead SciencesEmmie de Wit, National Institute of Allergy and Infectious Diseases, National Institutes of Health, HamiltonMark Denison, Vanderbilt UniversityMatthew Disney, Scripps Research, JupiterCourtney Fletcher, University of Nebraska Medical CenterStephanie L Ford-Scheimer, National Institutes of Health, RockvilleMatthias Gotte, University of AlbertaAbigail C Grossman, National Institutes of Health, RockvilleFrederick G Hayden, University of VirginiaDaria J Hazuda, Merck & Co, IncCharlotte A Lanteri, Walter Reed Army Institute of ResearchHilary Marston, National Institute of Allergy and Infectious Diseases, NIH, BethesdaAndrew D Mesecar, Purdue UniversityStephanie Moore, University of Alabama BirminghamJennifer O Nwankwo, 1910 Genet IncJules O'Rear, US FDAGeorge Painter, Emory UniversityKumar Singh Saikatendu, Takeda California IncCelia A Schiffer, University of MassachusettsTimothy P Sheahan, University of North CarolinaPei-Yong Shi, University of Texas Medical BranchHugh D Smyth, University of Texas AustinMichael J Sofia, Arbutus Biopharma IncMarla Weetall, PTC Therapeut IncSandra K Weller, University of ConnecticutRichard Whitley, University of Alabama BirminghamAnthony S Fauci, National Institute of Allergy and Infectious Diseases, NIH, BethesdaChristopher P Austin, National Institutes of Health, RockvilleFrancis S Collins, National Institutes of Health, BethesdaAnthony J Conley, National Institute of Allergy and Infectious Diseases, National Institutes of Health, BethesdaMindy Davis, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda
Authors:Anne Y. Lai, G1 Therapeutics IncJessica A. Sorrentino, G1 Therapeutics IncKonstantin H. Dragnev, Dartmouth Hitchcock Medical CenterJared M. Weiss, University of North CarolinaTaofeek Owonikoko, Emory UniversityJulie A. Rytlewski, Adaptive Biotechnologies CorpJill Hood, Adaptive Biotechnologies CorpZhao Yang, G1 Therapeutics IncRajesh K. Malik, G1 Therapeutics IncJay C. Strum, G1 Therapeutics IncPatrick J. Roberts, G1 Therapeutics Inc